Franklin Covey (FC) Q4 2026 Earnings Call Transcript

Franklin Covey reported fiscal 2026 revenue of $261.5 million, down 2%, while adjusted EBITDA edged up to $28.9 million from $28.8 million; fourth-quarter adjusted EBITDA increased 9% to $12.8 million. Enterprise North America invoiced amounts rose 4% to $151.4 million and deferred revenue increased 17% to $59.2 million, supporting fiscal 2027 guidance of $253 million-$273 million in constant-currency revenue and $29 million-$34 million in adjusted EBITDA. The company expects about $2 million less reported revenue from transitioning China operations to a local licensee, with no material adjusted EBITDA impact, and repurchased $28.1 million of shares during fiscal 2026.

Analysis

The key underwriting question is conversion, not bookings: longer contracts and deferred revenue improve visibility only if delivery schedules, renewals and collections turn them into revenue and cash without eroding service margins. The evidence is mixed: North American deferred revenue is supportive, but Education deferred revenue fell, free cash flow weakened, and logo retention slipped. A 20% hunter expansion plus higher lead-generation spend also puts costs ahead of wins; productivity measured against the pre-transformation period may not persist as the team scales. AI-adoption work could open CIO budgets, but management’s description suggests some engagements may be episodic rather than recurring, so do not capitalize them like durable subscriptions absent renewal data.

Near term, expect noisy comparisons and potential disappointment if first-quarter invoicing falls as flagged. Over 1–3 months, watch bookings-to-revenue conversion, renewal/logo retention, and cash generation—not just invoiced amounts. Over 6–18 months, the bull case is incremental revenue flowing through a largely built sales hub into EBITDA; the bear case is higher acquisition costs, delayed education awards, or weaker renewals preventing operating leverage. Buybacks alongside a stated cash-rebuild priority and reliance on an available credit facility make free-cash-flow conversion a relevant constraint, not an afterthought.

There is also a material source-quality issue: the summary gives fiscal 2027 revenue guidance of $263–273 million, while the transcript gives $253–273 million in constant currency. Verify the filed release before modeling or trading. Without valuation, current price, and verified guidance, the earnings signal alone does not justify a high-conviction directional position.

Key Decisions for Investors

• No immediate directional trade on this transcript alone. First reconcile the revenue-guidance range against the company’s official filing/release; the discrepancy materially changes the downside case.
• For an existing or prospective FC long, treat Q1 as a confirmation checkpoint: require evidence that North American invoiced activity rebounds after the flagged comparison and that deferred revenue converts into reported revenue without gross-margin deterioration.
• Track logo retention, Education contract awards and renewal timing, and operating cash flow/free cash flow alongside EBITDA. A further retention decline, repeated education delays, or weak cash conversion would falsify the operating-leverage thesis and argue for reducing exposure.
• If verified guidance and valuation support a long, scale in only after conversion evidence rather than buying the bookings narrative; avoid a short based solely on reported revenue weakness because the deferred-revenue trend could support a later recovery.